Address
Email address
Phone number
Website
Kevelt is an Estonian pharmaceutical company that is engaged in the manufacturing, resale and subcontracting of pharmaceuticals.
Name
Aktsiaselts KEVELT
Registry code
10418580
VAT number
EE100140077
Type
AS - Joint Stock Company
Status
Registered
Foundation date
24.03.1998 (26)
Financial year
01.01-31.12
Capital
127 800.00 €
Activity
74901 - Other professional, scientific and technical activities n.e.c. 21201 - Manufacture of pharmaceutical preparations
2 544 589 €
-25 717 €
-1%
-
1 082 025 €
27
Submitted
No tax arrears
-2%
-0%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Aleksei Shafranov 10.12.1979 (44) | - | Board member | - | |
Allan Ahtloo 20.02.1973 (51) | - | Board member | - | |
Kirill Surkov 21.06.1968 (56) | - | - | - | Board member |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Cayman Europe OÜ 11100176 | - | - | - | Founder |
2019 17.06.2020 | 2020 01.06.2021 | 2021 06.06.2022 | 2022 15.06.2023 | 2023 26.04.2024 | |
---|---|---|---|---|---|
Total Revenue | 2 818 384 € | 2 505 547 € | 2 720 817 € | 2 255 486 € | 2 544 589 € |
Net profit (loss) for the period | 1 368 657 € | -1 302 981 € | -178 562 € | -394 338 € | -25 717 € |
Profit Margin | 49% | -52% | -7% | -17% | -1% |
Current Assets | 11 397 403 € | 5 383 417 € | 5 869 964 € | 5 596 266 € | 5 475 769 € |
Fixed Assets | 655 223 € | 411 327 € | 314 218 € | 190 173 € | 170 490 € |
Total Assets | 12 052 626 € | 5 794 744 € | 6 184 182 € | 5 786 439 € | 5 646 259 € |
Current Liabilities | 2 823 120 € | 4 028 998 € | 4 514 128 € | 4 531 911 € | 4 494 385 € |
Non Current Liabilities | 156 724 € | 85 104 € | 167 974 € | 146 786 € | 69 849 € |
Total Liabilities | 2 979 844 € | 4 114 102 € | 4 682 102 € | 4 678 697 € | 4 564 234 € |
Share Capital | 146 459 € | 127 800 € | 127 800 € | 127 800 € | 127 800 € |
Equity | 9 072 782 € | 1 680 642 € | 1 502 080 € | 1 107 742 € | 1 082 025 € |
Employees | 36 | 31 | 31 | 26 | 27 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 644 444.9 € | 76 778.36 € | 82 025.65 € | 36 |
2023 Q4 | 978 397.12 € | 138 334.93 € | 142 516.96 € | 33 |
2023 Q3 | 498 788.36 € | 138 808.43 € | 143 425.29 € | 32 |
2023 Q2 | 868 188.08 € | 106 260.5 € | 109 979.44 € | 30 |
2023 Q1 | 190 607.16 € | 90 786.71 € | 94 513.69 € | 29 |
2022 Q4 | 773 050.02 € | 77 829.47 € | 80 820.35 € | 29 |
2022 Q3 | 636 915.34 € | 92 204.96 € | 95 988.63 € | 28 |
2022 Q2 | 884 939.81 € | 67 166.79 € | 72 275.76 € | 31 |
2022 Q1 | 676 056.53 € | 73 833.65 € | 78 398.9 € | 34 |
2021 Q4 | 1 583 228.88 € | 112 039.38 € | 116 174.78 € | 34 |
2021 Q3 | 515 791.95 € | 114 700.17 € | 119 449.94 € | 32 |
2021 Q2 | 1 046 157.43 € | 62 453.39 € | 67 152.89 € | 34 |
2021 Q1 | 700 355.25 € | 63 557.78 € | 67 967.69 € | 38 |
2020 Q4 | 1 037 995.2 € | 102 166.6 € | 105 646.58 € | 37 |
2020 Q3 | 764 928.49 € | 82 037.7 € | 86 326.61 € | 36 |
2020 Q2 | 771 366.31 € | 98 099.48 € | 100 293.45 € | 38 |
2020 Q1 | 497 062.7 € | 85 082.83 € | 90 767.91 € | 37 |